Transcutaneous Electrical Nerve Stimulation Treatment of Renal Colic
- Conditions
- Renal Colic
- Interventions
- Device: TENSDevice: placebo group
- Registration Number
- NCT03237208
- Lead Sponsor
- Adiyaman University Research Hospital
- Brief Summary
The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department.
- Detailed Description
Renal colic, an intensely painful condition, is a common presenting complaint to the emergency department. Parenteral opioids, nonsteroidal anti-inflammatory drugs and acetaminophen are commonly used to provide relief from renal colic. The aim of the present trial was to investigate the analgesic efficacy and safety of Transcutaneous electrical nerve stimulation treatment in patients with renal colic within the emergency department.
Study Design and Setting: A prospective, randomized, double-blind, placebo controlled, single-center, clinical trial will be conducted in emergency department of a tertiary care university hospital.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Adult patients with renal colic admitted to emergency department.
- Adult patients who were definitively diagnosed with acute renal colic due to urinary system stones using unenhanced computed abdominopelvic tomography
- Patients below 18 years of age
- Patients with haemodynamic instability, with fever (temperature=38°C [100.4°F]), with evidence of peritoneal inflammation,
- Patients using any analgesic within the previous 48 hours of emergency department presentation
- Patients who declined to participate
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description TENS TENS Patients receiving the real transcutaneous electrical nerve stimulation (TENS) with 100 hertz, pulse width 200 microseconds, voltage 2 milliampere placebo group placebo group Patients receiving the application of transcutaneous electrical nerve stimulation, but transcutaneous electrical nerve stimulation will not be activated.
- Primary Outcome Measures
Name Time Method Reduction of the intensity of pain 0 minutes, 15 minutes and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application Subjects will complete 100 mm visual analog scales at time zero, 15 and 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application
- Secondary Outcome Measures
Name Time Method Adverse events 30 minutes after 30 minutes after taking Transcutaneous Electrical Nerve Stimulation application
Trial Locations
- Locations (1)
Adiyaman University Research Hospital
🇹🇷Adıyaman, Central, Turkey